Thus, the current study was to investigate the possible role of CDK5 in the tumorigenesis and aggressiveness of glioma and emphasized the relationship of CDK5 expression with Ki-67 labeling index (LI), which represents the status of tumor cell proliferation. The gene discussed is CDK5; the disease is glioma.